# US 2005/0038242 A2 · Pyrrolothiazine and pyrrolothiazephine compounds having serotonin-2 receptor antagonistic and alpha-1-blocking action

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2005/0038242 A2
- Document ID: US20050038242A2
- Status: Published application
- Kind: A2
- Application number: 10/615,836
- Filed: 2003-07-10
- Published: 2005-02-17
- Earliest claimed: 1997-12-26
- Assignees: Daiichi Suntory Pharma Co., Ltd.
- Inventors: Akira MIZUNO; Makoto SHIBATA; Tomoe KAMEI; Harukazu FUKAMI; Norio INOMATA
- Web page: https://patentgrep.com/patent/US20050038242A2

## CPC

- C07D 513/04: Ortho-condensed systems
- A61P 9/00: Drugs for disorders of the cardiovascular system
- A61P 9/02: Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
- A61P 9/06: Antiarrhythmics
- A61P 9/08: Vasodilators for multiple indications
- A61P 9/10: for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A61P 9/12: Antihypertensives
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C07D 207/36: Oxygen or sulfur atoms
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

Abstract of the Disclosure A pyrrolesulfonamide derivative, Compound (I), which has strong serotonin-2 receptor antagonistic action and low toxicity and less side effects, and is useful as a therapeutic for circulatory diseases such as ischemic heart diseases, cerebrovascular disturbances and peripheral circulatory disturbances.

## Claims

### Claim 1

A pyrrolesulfonamide derivative or a salt thereof, said pyrrolesulfonamide derivative being represented by the following formula (I):
wherein
the ring p represented by
means a pyrrole ring represented by the following structure:
in which R represents an alkyl group, a cycloalkyl group, a cycloalkyl-alkyl group or a substituted or unsubstituted aralkyl group;
the dashed line indicates the presence or absence of a bond; and, when the bond indicated by the dashed line is present, Z2 is not present and Z1 represents a hydrogen atom but, when the bond indicated by the dashed line is absent, Z1 represents a hydrogen atom and Z2 represents a hydroxyl group; or Z1 and Z2 are combined together to represent an oxygen atom or a group NOR1 in which R1 represents a hydrogen atom, a substituted or unsubstituted alkyl group, a substituted or unsubstituted aralkyl group or a substituted or unsubstituted aryl group;
l represents 0 or 1;
A represents a substituted or unsubstituted alkylene group, a substituted or unsubstituted alkenylene group or a substituted or unsubstituted alkynylene group; and
Y represents a group
in which W represents CH, C═ or a nitrogen atom; and, when W represents CH, m stands for 0 or 1, B represents a carbonyl group, a sulfonyl group, an alkylene group, an alkenylene group, a group -C(OH)R2- in which R2 represents a substituted or unsubstituted aryl group, a group -CHR3- in which R3 represents a substituted or unsubstituted aryl group, or a substituted or unsubstituted cyclic or acyclic acetal group; when W represents C═, m stands for 1, B represents a group
in which the double bond is coupled with W and R4 represents a substituted or unsubstituted aryl group-or a substituted or unsubstituted aralkyl group; when W represents a nitrogen atom, m stands for 0 or 1, and B represents a carbonyl group, a sulfonyl group, an alkylene group, an alkenylene group or a group -CHR5- in which R5 represents a substituted or unsubstituted aryl group; E1 and E2 each independently represents a hydrogen atom or a lower alkyl group; and D represents a substituted or unsubstituted aromatic hydrocarbon group or a substituted or unsubstituted aromatic heterocyclic group.

### Claim 2 (depends on 1)

A pyrrolesulfonamide derivative or a salt thereof according to claim 1, wherein in the formula (I), Z1 represents a hydrogen atom and Z2 represents a hydroxyl group.

### Claim 3 (depends on 1)

A pyrrolesulfonamide derivative or a salt thereof according to claim 1, wherein in the formula (I), Z1 and Z2 are combined together to represent an oxygen atom or a group NOH.

### Claim 4 (depends on 1, 2, 3)

A pyrrolesulfonamide derivative or a salt thereof according to claim 1, 2 or 3, wherein in the formula (I), A is a trimethylene group.

### Claim 5 (depends on 1, 2, 3, 4)

A pyrrolesulfonamide derivative or a salt thereof according to claim 1, 2, 3 or 4, wherein in the formula (I), W represents a nitrogen atom, m stands for 0, and D represents a substituted or unsubstituted phenyl group.

### Claim 6 (depends on 1, 2, 3, 4, 5)

A pyrrolesulfonamide derivative or a salt thereof according to claim 1, 2, 3, 4 or 5, wherein in the formula (I), E1 and E2 both represent hydrogen atoms.

### Claim 7 (depends on 1, 2, 3, 4, 5, 6)

A pyrrolesulfonamide derivative or a salt thereof according to claim 1, 2, 3, 4, 5 or 6, wherein in the formula (I), the ring P represents the following formula:
wherein R has the same meaning as defined above.

### Claim 8

A process for the preparation of a pyrrolesulfonamide derivative represented by the following formula (Ia):
wherein A, the ring P, Y and l have the same meanings as defined above, which comprises:
reacting a compound, which is represented by the following formula (III):
X-A-X’ (III)
wherein A has the same-meaning as defined above and X and X’ represent the same or different eliminative groups, to a compound represented by the following formula (II):
wherein the ring P and l have the same meanings as defined above, thereby obtaining a compound represented by the following formula (IV):
wherein A, the ring P, X and l have the same meanings as defined above; and then
reacting a nitrogen-containing compound represented by the following formula (V):
H-Y (V)
wherein Y has the same meaning as defined above.

### Claim 9

A process for the preparation of a pyrrolesulfonamide derivative represented by the following formula (Ia):
wherein A, the ring P, Y and l have the same meanings as defined above, which comprises:
reacting a compound, which is represented by the following formula (VI):
X-A-Y (VI)
wherein A, X and Y have the same meanings as defined above, to a compound represented by the following formula (II):
wherein the ring P and l have the same meanings as defined above.

### Claim 10

A process for the preparation of a pyrrolesulfonamide derivative represented by the following formula (Ic):
wherein A, the ring P, R1 and l have the same meanings as defined above, and Y’ represents a group
in which when W represents CH, B’ represents a sulfonyl group, an alkylene group, an alkenylene group, a group -C(OH)R2- in which R2 represents a substituted or unsubstituted aryl group, a group -CHR3- in which R3 represents a substituted or unsubstituted aryl group, or a substituted or unsubstituted cyclic or acyclic acetal group; when W represents C═, B’ represents a group
in which the double bond is coupled with W and R4 represents a substituted or unsubstituted aryl group or a substituted or unsubstituted aralkyl group; when W represents a nitrogen atom, B’ represents a carbonyl group, a sulfonyl group, an alkylene group, an alkenylene group or a group -CHR5- in which R5 represents a substituted or unsubstituted aryl group; and D, E1, E2 and m have the same meanings as defined above, which comprises:
reacting a hydroxylamine or a derivative thereof, which is represented by the following formula (VII):
NH2OR1 (VII)
wherein R1 has the same meaning as defined above, with a pyrrolesulfonamide derivative represented by the following formula (Ib):
wherein A, the ring P, Y’ and l have the same meanings as defined above.

### Claim 11

A process for the preparation of a pyrrolesulfonamide derivative represented by the following formula (Id):
wherein A, the ring P, Y’ and l have the same meanings as defined above, which comprises:
reducing a pyrrolesulfonamide derivative represented by the following formula (Ib):
wherein A, the ring P, Y’ and l have the same meanings as defined above.

### Claim 12

A process for the preparation of a pyrrolesulfonamide derivative represented by the following formula (Ie):
wherein A, the ring P, R1, Y and l have the same meanings as defined above, which comprises: reacting a hydroxylamine or a derivative thereof, which is represented by the following formula (VII):
NH2OR1 (VII)
wherein R1 has the same meaning as defined above, to a compound represented by the following formula (IV):
wherein A, the ring P, X and l have the same meanings as defined above, thereby obtaining a compound represented by the following formula (VIII):
wherein A, the ring P, R1, X and l have the same meanings as defined above; and then
reacting a nitrogen-containing compound represented by the following formula (V):
H-Y (V)
wherein Y has the same meaning as defined above.

### Claim 13

A process for the preparation of a pyrrolesulfonamide derivative represented by the following formula (If):
wherein A, the ring P, Y and l have the same meanings as defined above, which comprises:
reducing a compound represented by the following formula (IV):
wherein A, the ring P, X and l have the same meanings as defined above, thereby obtaining a compound represented by the following formula (IX):
wherein A, the ring P, X and l have the same meanings as defined above; and then reacting a nitrogen-containing compound represented by the following formula (V):
H-Y (V)
wherein Y has the same meaning as defined above.

### Claim 14

A process for the preparation of a pyrrolesulfonamide derivative represented by the following formula (Ig):
wherein A, the ring P, Y and l have the same meanings as defined above, which comprises:
subjecting a compound, which is represented by the following formula (IX):
wherein A, the ring P, X and l have the same meanings as defined above, to dehydration treatment, thereby obtaining a compound represented by the following formula (X):
wherein A, the ring P, X and l have the same meanings as defined above; and then
reacting a nitrogen-containing compound represented by the following formula (V):
H-Y (V)
wherein Y has the same meaning as defined above.

### Claim 15

A process for the preparation of a pyrrolesulfonamide derivative represented by the following formula (Ig):
wherein A, the ring P, Y and l have the same meanings as defined above, which comprises:
subjecting a compound, which is represented by the following formula (If):
wherein A, the ring P, Y and l have the same meanings as defined above, to dehydration treatment.

### Claim 16

A compound represented by the following formula (II):
wherein the ring P and l have the same meanings as defined above.

### Claim 17

A compound represented by the following formula (XI):
wherein the dashed line, A, the ring P, X, Z1, Z2 and l have the same meanings as defined above.

### Claim 18

A process for the preparation of a pyrrolesulfonamide derivative represented by the following formula (IIa) or (IIa’):
wherein R and l have the same meanings as defined above, which comprises:
converting a 1-substituted-pyrrole-3-sulfonic acid or a salt thereof, which is represented by the following formula (XII):
wherein M represents a hydrogen ion, an alkali metal ion, an alkaline earth metal ion or a quaternary ammonium ion, p stands for 1 when M represents a hydrogen ion, an alkali metal ion or a quaternary ammonium ion or p stands for 2 when M represents an alkaline earth metal ion, q stands for 0 or 1, and R has the same meaning as defined above, into a compound represented by the following formula (XIII):
wherein X” represents a chlorine atom or a bromine atom; causing glycine or β-alanine or a derivative thereof, which is represented by the following formula (XIV):
NH2(CH2)lCH2COOR6 (XIV)
wherein R6 represents a hydrogen atom or a carboxyl-protecting group, to act, thereby obtaining a compound represented by the following formula (XV):
wherein R, R6 and l have the same meanings as defined above; and then subjecting said compound to ring closure.

### Claim 19

A process for the preparation of a pyrrolesulfonamide derivative represented by the following formula (IIa) or (IIa’):
wherein R and l have the same meanings as defined above, which comprises: reacting a compound, which is represented by the formula (XVIa) or (XVIb):
R-X”’ (XVIa) (RO)2SO2 (XVIb)
wherein X”’ represents an eliminative group and R has the same meaning as defined above, with a compound represented by the following formula (IIb) or (IIb’):
wherein l has the same meaning as defined above.

### Claim 20

A compound represented by the following formula (XV):
wherein R, R6 and l have the same meanings as defined above.

### Claim 21

A compound represented by the following formula (XII):
wherein M, R, p and q have the same meanings as defined above.

### Claim 22 (depends on 21)

A compound according to claim 21, wherein in the formula (XII), R is a methyl group, M is a sodium ion, p is 1, and q is 0 or 1.

### Claim 23

A process for the preparation of a 1-substituted-pyrrole-3-sulfonic acid or a salt thereof, which comprises treating a 1-substituted-pyrrole with sulfur trioxide-pyridine complex.

### Claim 24

A process for the preparation of a compound represented by the following formula (XII):
wherein M, R, p and q have the same meanings as defined above, which comprises treating a compound, which is represented by the following formula (XVII):
wherein R has the same meaning as defined above, with trimethylsilyl chlorosulfonate, followed by alkali hydrolysis.

### Claim 25 (depends on 1)

A pharmaceutical comprising, as an effective ingredient, a pyrrolesulfonamide derivative or a salt thereof according to claim 1.

### Claim 26 (depends on 1)

A therapeutic for circulatory diseases, comprising as an effective ingredient a pyrrolesulfonamide derivative or a salt thereof according to claim 1.

### Claim 27 (depends on 1)

A serotonin-2 receptor antagonist, comprising as an effective ingredient a pyrrolesulfonamide derivative or a salt thereof according to claim 1.
